Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
38.44
-1.94 (-4.80%)
Sep 23, 2026, 4:00 PM EDT - Market closed
Septerna Employees
Septerna had 123 employees as of June 30, 2026.
Employees
123
Change
n/a
Growth
n/a
Revenue / Employee
$803,919
Profits / Employee
-$197,041
Market Cap
1.79B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 123 | - | - |
| Mar 31, 2026 | 123 | 48 | 64.00% |
| Dec 31, 2025 | 130 | 55 | 73.33% |
| Dec 31, 2024 | 75 | - | - |
| Sep 30, 2024 | 73 | - | - |
| Jun 30, 2024 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Maravai LifeSciences Holdings | 415 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Xencor | 260 |
| Zymeworks | 231 |
| Lakefront Biotherapeutics NV | 196 |
| Stoke Therapeutics | 170 |
SEPN News
- 13 days ago - Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Septerna Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 15 days ago - Septerna Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 22 days ago - Septerna to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer - GlobeNewsWire
- 5 weeks ago - Septerna price target raised to $48 from $38 at JPMorgan - TheFly
- 5 weeks ago - Septerna price target raised to $60 from $40 at H.C. Wainwright - TheFly
- 5 weeks ago - Septerna price target raised to $62 from $43 at Jones - TheFly